News

Lupin partners with SUP to commercialize Tiotropium DPI in China, aiming to improve respiratory health with innovative products.
People with one of more than 20 breathing conditions could be eligible for up to £749 a month from the Department for Work ...
Posttraumatic stress disorder in veterans with HIV increases the risk for AIDS and multiple chronic conditions, especially in ...
Lupin partners with SUP to commercialize Tiotropium DPI in China for COPD treatment, expanding respiratory care options.
Lupin & Sino Universal Pharmaceuticals ink license and supply agreement for tiotropium DPI in China: Our Bureau, Mumbai Monday, June 16, 2025, 14:30 Hrs [IST] Global pharma major ...
Mumbai: Global pharma major Lupin Limited has signed a supply and license agreement with Sino Universal Pharmaceuticals (SUP) ...
As per the agreement, SUP will obtain regulatory approvals for selling Tiotropium DPI in China, while Lupin will be the ...
Under the terms of the agreement, SUP will be responsible for obtaining the necessary regulatory approvals to sell Tiotropium ...
The following is a summary of “Triple overlap of COPD, severe obesity, and high risk of OSA: insights from an NHANES analysis ...
New Partnership with Leonard Nimoy’s Daughter Aims to Raise COPD Awareness ...
Long-standing inflammatory disorders, including COPD and GERD, signal heightened risk for lung cancer among never-smokers, ...